{"log_id": 8741055043290095472, "direction": 0, "words_result_num": 30, "words_result": [{"probability": {"variance": 0, "average": 0.99539, "min": 0.99539}, "location": {"width": 23, "top": 0, "height": 22, "left": 1165}, "words": "国"}, {"probability": {"variance": 3.6e-05, "average": 0.995762, "min": 0.985455}, "location": {"width": 87, "top": 181, "height": 23, "left": 192}, "words": "核准日期"}, {"probability": {"variance": 2.1e-05, "average": 0.995382, "min": 0.988549}, "location": {"width": 98, "top": 222, "height": 26, "left": 190}, "words": "修改日期:"}, {"probability": {"variance": 2e-06, "average": 0.998804, "min": 0.99579}, "location": {"width": 597, "top": 263, "height": 58, "left": 325}, "words": "低分子量肝素钠注射液说明书"}, {"probability": {"variance": 1e-06, "average": 0.999171, "min": 0.996396}, "location": {"width": 376, "top": 350, "height": 29, "left": 427}, "words": "请仔细阅读说明书并在医师指导下使用"}, {"probability": {"variance": 0.0016, "average": 0.990126, "min": 0.751286}, "location": {"width": 825, "top": 392, "height": 33, "left": 234}, "words": "警示语:椎管或硬膜外血肿。当实施椎管内麻醉(脊麻和硬膜外麻醉)或椎管穿刺时"}, {"probability": {"variance": 0.000201, "average": 0.995821, "min": 0.913019}, "location": {"width": 873, "top": 434, "height": 35, "left": 189}, "words": "应注意,使用低分子肝素或肝素类物质预防血栓并发症的病人,有可能引起椎管或硬膜外"}, {"probability": {"variance": 4.5e-05, "average": 0.996605, "min": 0.968731}, "location": {"width": 874, "top": 476, "height": 35, "left": 187}, "words": "血肿,导致长期甚至永久性瘫痪。放置硬膜外导管或反复硬膜外穿刺,合并使用影响止血"}, {"probability": {"variance": 0.000116, "average": 0.996242, "min": 0.936819}, "location": {"width": 876, "top": 519, "height": 36, "left": 186}, "words": "功能的药物,如非甾体类抗炎药( NSAIDS)、血小板凝制剂或其他抗凝药物等,血肿发生率"}, {"probability": {"variance": 4.6e-05, "average": 0.997129, "min": 0.960878}, "location": {"width": 852, "top": 563, "height": 34, "left": 185}, "words": "可能会更高。此种情况,应监测病人神经损害的症状和体征,如发现有可能损伤到神经"}, {"probability": {"variance": 7.2e-05, "average": 0.99594, "min": 0.95371}, "location": {"width": 822, "top": 608, "height": 31, "left": 185}, "words": "应紧急处理。医生在对此类病人实施椎管内干预(麻醉或穿刺)时,应进行利弊权衡"}, {"probability": {"variance": 0, "average": 0.999519, "min": 0.99808}, "location": {"width": 123, "top": 696, "height": 27, "left": 191}, "words": "【药品名称】"}, {"probability": {"variance": 1e-06, "average": 0.999287, "min": 0.99592}, "location": {"width": 336, "top": 738, "height": 28, "left": 229}, "words": "通用名:低分子量肝素钠注射液"}, {"probability": {"variance": 0, "average": 0.999669, "min": 0.999451}, "location": {"width": 183, "top": 783, "height": 28, "left": 228}, "words": "商品名:吉派林"}, {"probability": {"variance": 0.000422, "average": 0.98346, "min": 0.943579}, "location": {"width": 609, "top": 827, "height": 26, "left": 227}, "words": "英文名: Low Molecular Weight Heparin Sodium Injection"}, {"probability": {"variance": 0.000108, "average": 0.991856, "min": 0.971565}, "location": {"width": 419, "top": 871, "height": 26, "left": 226}, "words": "汉语拼音: Difenziliang Gansuna Zhushey"}, {"probability": {"variance": 2.6e-05, "average": 0.996452, "min": 0.987731}, "location": {"width": 78, "top": 912, "height": 27, "left": 188}, "words": "【成分】"}, {"probability": {"variance": 2.5e-05, "average": 0.998178, "min": 0.970253}, "location": {"width": 823, "top": 952, "height": 31, "left": 226}, "words": "本品主要成份为低分子量肝素钠,系由肝素钠裂解获取的硫酸氨基葡聚糖片断的钠盐"}, {"probability": {"variance": 1e-06, "average": 0.999346, "min": 0.997676}, "location": {"width": 121, "top": 1002, "height": 25, "left": 180}, "words": "其结构式为:"}, {"probability": {"variance": 0, "average": 0.993953, "min": 0.993763}, "location": {"width": 235, "top": 987, "height": 77, "left": 814}, "words": "杭州"}, {"probability": {"variance": 0.010648, "average": 0.963845, "min": 0.637687}, "location": {"width": 143, "top": 1179, "height": 24, "left": 823}, "words": "R=COCH3或SO3"}, {"probability": {"variance": 0.001228, "average": 0.985544, "min": 0.851445}, "location": {"width": 373, "top": 1222, "height": 30, "left": 178}, "words": "分子量:平均分子量小于8000尔顿"}, {"probability": {"variance": 3.4e-05, "average": 0.997212, "min": 0.97257}, "location": {"width": 479, "top": 1266, "height": 28, "left": 176}, "words": "分子量小于8000道尔顿的低分子肝素钠大于60%"}, {"probability": {"variance": 0.00014, "average": 0.993131, "min": 0.966809}, "location": {"width": 149, "top": 1311, "height": 26, "left": 222}, "words": "辅料:氯化钠"}, {"probability": {"variance": 0, "average": 0.999528, "min": 0.999062}, "location": {"width": 79, "top": 1353, "height": 29, "left": 180}, "words": "【性状】"}, {"probability": {"variance": 1e-05, "average": 0.997718, "min": 0.99048}, "location": {"width": 297, "top": 1396, "height": 27, "left": 218}, "words": "本品为无色或淡黄色澄明液体"}, {"probability": {"variance": 2e-06, "average": 0.9986, "min": 0.996379}, "location": {"width": 100, "top": 1440, "height": 25, "left": 180}, "words": "【适应症】"}, {"probability": {"variance": 6.9e-05, "average": 0.996597, "min": 0.966095}, "location": {"width": 433, "top": 1481, "height": 27, "left": 215}, "words": "1.急性深静脉血栓形成(DVT)的抗凝治疗"}, {"probability": {"variance": 2.2e-05, "average": 0.998411, "min": 0.981343}, "location": {"width": 314, "top": 1524, "height": 27, "left": 215}, "words": "2.预防血液透析时血凝块形成"}, {"probability": {"variance": 7e-06, "average": 0.998024, "min": 0.989688}, "location": {"width": 739, "top": 1565, "height": 30, "left": 255}, "words": "与阿司匹林联合使用,预防不稳定型心绞痛和非Q波心肌梗塞的缺血并发症"}], "language": 3}